ABBV vs OSCR

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

Oscar Health Inc. continues to demonstrate strong momentum and validate its 10x growth potential. The most significant development since the last analysis is CEO Mark T. Bertolini's substantial $11.92 million share purchase, signaling high insider confidence and reinforcing the company's strategic direction. This, combined with favorable 2027 Medicare rate hikes and a subsequent 22% stock rally, b...